Treprostinil and Skullcap: Interaction Details

Brand names
Treprostinil
OrenitramTyvasoRemodulin +2 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Treprostinil

Brand names
  • Orenitram
  • Tyvaso
  • Remodulin
  • Yutrepia
  • Tyvaso DPI

Skullcap

We don't have a drug information page for Skullcap yet. Have a question about Skullcap? Ask a pharmacist, free →

What Happens When You Take Treprostinil With Skullcap

What can happen when they are taken together (rated Moderate)

Increased risk of bleeding

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

In theory, combining skullcap with drugs could lead to excessive bleeding. In rats, flavonoid constituents of skullcap inhibited aggregation, and some of these constituents were as active as aspirin or more so.1 Caution is recommended.

The Treprostinil and Skullcap Interaction, Explained

Taking skullcap with treprostinil may raise your chance of bleeding. Treprostinil helps open blood vessels and also makes (the cells that help blood clot) less sticky. Skullcap, an herbal supplement, has shown similar anti-clotting effects in lab studies in rats. So together they could add up, leading to easier bruising, nosebleeds, bleeding gums, or longer bleeding from cuts. This is a theoretical concern and has not been proven in people.

Please tell your pharmacist or doctor if you take or plan to take skullcap. Your care team can keep a closer eye on you and help you decide what is safest. Don't stop either one on your own.

Theoretical interaction (moderate, delayed onset): effect and increased bleeding risk.

  • Mechanism: treprostinil (prostacyclin analog) inhibits aggregation via IP receptor activation and cAMP elevation. Skullcap flavonoids inhibited platelet aggregation in rats (some comparable to or exceeding aspirin) and may impair fibrinogen conversion to fibrin.
  • Evidence: theoretical, based on animal and in vitro data; no human data or quantified effect on exposure.
  • Management: use caution; monitor for signs and symptoms of excessive bleeding (bruising, epistaxis, gingival or bleeding). Ask patients about herbal supplement use, and consider discouraging use if bleeding risk is otherwise elevated (e.g., concurrent or antiplatelets).

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Treprostinil and Skullcap Interact

The likely mechanism

of aggregation and the conversion of fibrinogen to fibrin by skullcap

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Treprostinil and Skullcap Interaction

Your care team can manage this, and the concern is mostly theoretical.

  • Keep taking your treprostinil as prescribed. Don't start or stop anything without talking to your pharmacist or doctor.
  • Tell your care team that you take or are thinking about taking skullcap, along with any other or supplements.
  • Your team may monitor you more closely for signs of bleeding.
  • Watch for unusual bruising, nosebleeds, bleeding gums, blood in urine or stool, or black stools, and report them promptly.

Seek urgent care for heavy bleeding that won't stop.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Treprostinil or Skullcap need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Studies on Scutellariae radix

    Flavonoids isolated from Scutellariae radix (skullcap) suppressed aggregation triggered by a variety of agents in rats. Aspirin 1 millimole (mmol) reduced collagen-induced platelet aggregation by 21.6%, while the same concentration of the flavonoids baicalein, baicalin, wogonin, wogonin-7-O-D-glucuronide, oroxylin A, skullcapflavone II, and chrysin reduced aggregation by 23.3%, 12.4%, 24.7%, 8.9%, 43.8%, 32.5%, and 23.4%, respectively.

    Aspirin 1 mmol reduced arachidonic acid induced platelet aggregation by 30.4%, whereas baicalein, baicalin, and wogonin at 1 mmol reduced aggregation by 47.7%, 31.3%, and 45.5%, respectively. Baicalein and baicalin also inhibited the conversion of fibrinogen to fibrin induced by thrombin.1

Treprostinil and Skullcap: Common Questions

How serious is the Treprostinil and Skullcap interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How is the Treprostinil and Skullcap interaction managed?

Your care team can manage this, and the concern is mostly theoretical. Keep taking your treprostinil as prescribed. Don't start or stop anything without talking to your pharmacist or doctor. Tell your care team that you take or are thinking about taking skullcap, along with any other or supplements. Your team may monitor you more closely for signs of bleeding. Watch for unusual brui… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Treprostinil and Skullcap Interaction

Ask in your own words about taking Treprostinil and Skullcap together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Kubo M, Matsuda H, Tani T, et al: Studies on Scutellariae radix. XII. Anti-thrombic actions of various flavonoids from Scutellariae radix. Chem Pharm Bull 1985; 33:2411-2415. PubMed
Was this write-up helpful?

Other Serious Interactions of Treprostinil and Skullcap

Also serious with Treprostinil

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Treprostinil

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring. This interaction.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks. This interaction.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.